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Objective:  To analyse,  based  on  an  anonymous  questionnaire,  the treatment  decision  envisaged  and  the
impact of  the  medical  information  delivered  in patients  facing  the  diagnosis  of  an  advanced  laryngeal
cancer  amenable  to  total  laryngectomy  or a  laryngeal  preservation  protocol.
Material and  methods:  Prospective  study  conducted  in a French  teaching  hospital  based  on  questionnaires
ﬁlled  in  by  269  patients  attending  the  otorhinolaryngology  clinic.
Results:  A total  of 28.6%  of patients  would  not  consider  any  trade-off  of  cure  to preserve  their  larynx;
1.4%  of  patients  were  willing  to trade all chances  of  cure  in  order  to avoid  total  laryngectomy.  The median
percentage  of cure  that  patients  were  ready  to loose  in  order  to  preserve  their  larynx  was  33% (range:  5
to 100%);  47.9%  of patients  wanted  to  receive  additional  information  before  making  their decision  with
a signiﬁcant  increase  among  patients  with  a level  of education  beyond  secondary  school  (P  = 0.0006)  and
among  patients  with  a family  history  of cancer  (P = 0.038).  The  additional  information  most  frequently
requested  concerned  the  complications  related  to  the  laryngeal  preservation  protocol  (34.1%) and  the
cure rate  (28.6%).  After  receiving  information  about  the  risk  of  tracheostomy  and  permanent  gastrostomy
following  the  laryngeal  preservation  protocol,  the percentage  of  subjects  who  would  not  consider  any
trade-off  in order  to  preserve  their  larynx  increased  to 31.2%  and  56.1%,  respectively.
Conclusion:  Laryngeal  preservation  is  not  a major  objective  of  treatment  shared  by patients  ﬁlling  a
questionnaire  devoted  to the  choice  of  treatment  when  facing  an  advanced  laryngeal  cancer.  Speciﬁc
information  concerning  the  expected  results  and  the inherent  risks  involved  in the  various  treatment
options  must  be provided  in  every  case.
© 2013  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
Laryngeal preservation protocols [1–8] and the patient’s right
o information have developed almost simultaneously in the ﬁeld
f head and neck cancer over the last 20 years in France [9].
lthough many studies in the medical literature have assessed
he indications, local control rate, survival and risks of tra-
heostomy and gastrostomy inherent to laryngeal preservation
rotocols for advanced (stage III–IV) laryngeal cancer [1–8], only
wo papers [10,11] have speciﬁcally analysed the patient’s deci-
ion when facing an advanced laryngeal cancer amenable to either
∗ Corresponding author. Tel.: +33 01 56 09 34 63.
E-mail address: ollivier.laccourreye@egp.aphp.fr (O. Laccourreye).
879-7296/$ – see front matter © 2013 Elsevier Masson SAS. All rights reserved.
ttp://dx.doi.org/10.1016/j.anorl.2013.06.001a total laryngectomy or a laryngeal preservation protocol using
chemotherapy and radiotherapy.
This prospective study, based on analysis of questionnaires
ﬁlled in by patients attending the otorhinolaryngology clinic of a
French teaching hospital, completes a preliminary study [11]. It was
designed to determine the degree of trade-off in terms of chance of
cure that patients would consider in order to preserve their larynx
and avoid total laryngectomy. It described the additional infor-
mation requested by these subjects and analysed the statistical
association between the desire to receive additional information
and various medical and sociodemographic variables. Finally, it
evaluated whether the written information provided concerning
the potential risks of tracheostomy and permanent gastrostomy
inherent to laryngeal preservation protocols modiﬁed the percent-
age of cure that these subjects would consider to trade in order to
preserve their larynx.
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Table 1
Medical and sociodemographic data.
Patients
Gender: male/female 168/101 (62.5%/37.5%)
Age: median – range (years) 52 – 16 to 88
Reason for visit to the ENT clinic*
Otology 67 (24.9%)
Rhinology 123 (45.7%)
Laryngology 44 (16.3%)
Head and neck disease 33 (12.2%)
Benign disease/cancer 233 (86. 6%)/36 (23.4%)
Sociodemographic data
Single 113/156 (42%/58%)
Dependent minors at home: Yes/No 173/96 (64.4%/35.6%)
Level of education
Brevet d’études 92 (34.2%)
Baccalaureat 45 (16.7%)
License 38 (14.1%)
Master 39 (14.4%)
Doctorate 55 (20.4%)
Actively employed (Yes/No)◦ 151/107 (56.1%/39.7%)
Medical data
Smoking: Yes/No 73/196 (27.1%/72.9%)
Personal history of cancer: Yes/No 56/213 (20.8%/79.2%)
If  yes, head and neck cancer vs
non-head and neck
38/18 (67.8%/32.2%)
Family history of cancer: Yes/No 140/269 (52%/48%)
If  yes, head and neck cancer vs
non-head and neck
11/129 (7.8%/92.2%)4 O. Laccourreye et al. / European Annals of Otorhino
. Material and methods
This prospective study was based on the analysis of 269
uestionnaires ﬁlled in consecutively during the month of June
010 by patients consulting four senior otorhinolaryngologists
O.L., D.M., M.M.  and P.B.) in a French teaching hospital. This
opulation represented a subgroup of the 398 patients who con-
ulted these surgeons during this period: 129 patients were
xcluded due to refusal to participate in this study (15), fail-
re to answer the questions of the questionnaire (40), ongoing
reatment for head and neck cancer (59) or a history of total
aryngectomy (15).
The questionnaire approved by our university’s ethics com-
ittee, validated by the psychiatry department (S.C.), tested on a
reliminary panel of 30 patients attending the otorhinolaryngology
linic and composed of four parts, was given to the subjects at the
nd of their visit.
The ﬁrst part of the questionnaire provided the subjects with the
ollowing information: “The following anonymous questionnaire is
iven to you in the setting of a study in attempt to evaluate the
actors that may  inﬂuence the decision that a person with a cancer
f the larynx (throat) at an advanced stage would take regarding
reatment. Please read carefully the following information before
nswering. We  realise that this type of exercise could make you feel
ncomfortable, but your opinion would be extremely useful to us.
In France, each year, several thousands of people are affected
ith advanced laryngeal (the throat) cancer. In the face of such
 tumor, two main treatments exist: total laryngectomy and
hemoradiation.
Total laryngectomy (complete resection of the larynx) is the
reatment that offers the highest cure rate (percentage of chances
o be alive without the disease). However, its completion leaves a
car in the neck, loss of respiration by the nose and the mouth, loss
f speech and the opening and suture of the trachea to the cervi-
al skin in order to allow for respiration. The risk of death related
o this operation is estimated to be less than 1%, a restoration of
peech may  be achieved in the vast majority of cases. Voice and
peech can be subsequently restored (either by learning how to
se air present in the oesophagus, called oesophageal speech, or by
lacing an implant in the neck, called voice prosthesis). The cure
ate (percentage of chances to be alive without the disease) after
he chemotherapy-radiotherapy treatment is inferior to the one
chieved with total laryngectomy. But this treatment option avoids
he scar, the loss of speech and the permanent opening in the neck
elated to the suture of the skin to the trachea.”
The second part of the questionnaire, presented in Table 1, col-
ected various medical and sociodemographic data concerning the
ubjects participating in this study.
In the third part of the questionnaire, subjects were asked to
nswer the following two questions:
“If you faced an advanced cancer of the larynx, would you
onsidered being treated with a chemotherapy and radiotherapy
rotocol to avoid total laryngectomy even if this treatment resulted
n a reduction of your cure rate (percentage of chances to be alive
ithout the disease). If you answer “Yes”, what reduction in the
ercentage of cure rate would you consider in order to avoid total
aryngectomy?”
In the fourth and last part of the questionnaire, subjects were
sked to answer the following three questions:
“Would you need more information in order to take your deci-
ion and if yes what type of information?
Would you consider to be treated by chemotherapy and radio-
herapy (to avoid total laryngectomy) if you were told that this
reatment is associated with a 1% risk of requiring a tracheostomy
ube (i.e. a prosthesis with an opening in the neck) in order to
reathe?*: missing data for 2 cases; ◦: missing data for 11 cases.
Would you consider to be treated by chemotherapy and radio-
therapy (to avoid total laryngectomy) if you were told that this
treatment is associated with a 1 to 5% risk of severe swallowing
disorders requiring permanent placement (i.e. for life) of a feeding
tube in your stomach?”
The data collected, stored on a personal computer, were ana-
lysed with Statview software (SAS, Berkeley, USA) in order to: (i)
deﬁne the percentage of trade in terms of cure rate that patients
would consider in order to preserve their larynx, (ii) describe the
additional information that subjects would like to receive, (iii)
determine whether there was  any statistical association between
the patients desire to receive additional information and the med-
ical and sociodemographic variables collected (Table 1) and (iv)
analyse the impact of written information concerning the poten-
tial risks of tracheostomy and/or permanent gastrostomy after
chemoradiation on the percentage of cure that patients would con-
sider to trade in order to preserve their larynx. The Chi2 and Fisher
t-tests, the nonparametric Mann-Whitney U test and the linear
regression method were used for analysis. Statistical signiﬁcance
was set at a P level of 0.05.
3. Results
A total of 28.6% (77/269) of patients would not consider any
trade of cure in order to preserve their larynx; 1.4% (4/269) of
patients were willing to trade all chances of cure in order to avoid
total laryngectomy. The median percentage survival that the sub-
jects would consider to trade in order to preserve their larynx was
33% (range: 5 to 100%) (Fig. 1).
In all, 47.9% (129/269) of patients wanted to receive additional
information before making their decision. On univariate analysis
(Table 2), two  variables were statistically related to the percentage
of patients willing to receive additional information. This percent-
age was signiﬁcantly higher when the patient’s level of education
exceeded secondary school (P = 0.006) and in patients with a family
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Table  2
Univariate analysis of variables affecting the desire to receive or not receive additional information.
Requests additional information Does not request additional information P
Gender: male vs female 80/49 88/52 0.9
Age  (years): median – range 51 – 16 to 88 55 – 21 to 84 0.064
Reason for visit at the ENT clinic*
O/R/L/H&N 34/59/19/16 33/64/24/17 0.4
Benign disease/cancer 114/15 19/21 0.4
Sociodemographic data
Single: Yes/No 57/72 56/84 0.5
Dependent minors at home: Yes/No 80/49 93/47 0.5
Level  of education: BEPC/Bac/L/M/D 34/14/22/25:34 58/31/16/14/21 0.0006
Actively employed: Yes/No 78/48 73/59 0.3
Medical data
Smoking: Yes/No 36/93 37/103 0.7
If  yes: cigarettes/day: median – range 10 – 1 to 50 15 – 2 to 45 0.1
Personal history of cancer: Yes/No 25/104 32/108 0.5
If  yes, head and neck cancer vs non-head and neck 9/16 19/13 0.1
Family history of cancer: Yes/No 76/53 64/75 0.038
If  yes, head and neck cancer vs non-head and neck 6/70 6/58 0.7
O ureat; L: license; M:  Master; D: Doctorate; n: number.
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Table 3
Additional information requested by 129 subjects.
Additional information requested % (n)
Cure rate of the two treatment options 28.6 (37)
Duration of treatment 7.7 (10)
Degree of extension of the disease 2.3 (3)
Quality of life after treatment 0.7 (1)
Time until treatment 0.7 (1)
Life  expectancy after treatment according to age 0.7 (1)
Complications, adverse effects and/or risks of
preservation
34.1 (44)
Possibility of salvage in the case of failure of
preservation
9.3 (12)
Meet with a laryngectomized patient 8.5 (11)
Rehabilitation and quality of speech after total
laryngectomy
6.2 (8)
Other risks of total laryngectomy 2.3 (3)
Tracheostomy management after total
laryngectomy
1.5 (2)
Quality of eating 1.5 (2)
Pain  management 0.7 (1): otology; R: rhinology; L: laryngology; H&N: head and neck disease; Bac: baccala
old  is used to increase visualisation of the signiﬁcant results.
istory of cancer (P = 0.038), although the type of cancer (head and
eck or non-head and neck) had no impact.
The additional information most frequently requested by
atients (Table 3) concerned complications, adverse effects and/or
isks related to the laryngeal preservation protocol (34.1%) and
he cure rates (28.6%). In contrast (Table 3), the surgical team’s
pinion (5.4%), another specialist’s opinion (5.4%), the general
ractitioner’s opinion (1.5%), the fact of not being able to take
his decision (2.3%), the need for more time to think about the
ecision (1.5%), the need to be reassured (0.7%), the duration of
reatment (0.7%) and/or tracheostomy management (2.5%) were
nly very rarely spontaneously reported by subjects requesting
dditional information. The possibility of salvage therapy in the
ase of failure of laryngeal preservation (7.7%), the desire to
eet with a laryngectomized patient (8.5%) and the simple desire
or more information without specifying the type of additional
nformation (12.4%) were situated between these extreme values
Table 3).
After reading the written information provided on the respec-
ive percentage risks associated with tracheostomy and permanent
astrostomy after a laryngeal preservation protocol, 31.2% (84/269)
nd 56.1% (151/269) of patients, respectively, ﬁnally decided that
-20
0
20
40
60
80
100
120
193 patients
ig. 1. Distribution (box and whisker plot) of the percentage chance of cure that
ubjects would consider to trade off in order to preserve their larynx.
Surgeon’s or attending team’s opinion 5.4 (7)
Other specialist opinion 5.4 (7)
General practitioner’s opinion 1.5 (2)
Requests more information, but cannot specify
what information
12.4 (16)
Claims that he/she is unable to decide 2.3 (3)
Requests time to think about the decision 1.5 (2)
Palliative care 1.5 (2)
Wants to be reassured 0.7 (1)
Possibilities of euthanasia 0.7 (1)
n: number.
they would not trade off the slightest chance of survival in order to
preserve their larynx.
4. Discussion
The French Law dated 4 March 2002, called “Patients’ rights
and quality of the health system” established that patients should
participate in medical decisions concerning them and that this
participation was  based on obtaining “free and informed consent”
after receiving “honest, clear and appropriate information” [6].
This law also requires the doctor to inform the patient about “the
various treatment options, their value, their possible degree of
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rgency, their consequences, the normally predictable frequent
r serious risks and the predictable consequences in the case
f refusal of treatment” [6]. This law is especially applicable to
dvanced (stage III–IV) laryngeal cancer, as chemotherapy and
adiotherapy laryngeal preservation protocols as an alternative to
he conventional treatment option, total laryngectomy, have been
eveloped over the last 20 years.
Laryngeal preservation protocols, validated by the American
ociety of Clinical Oncology [5], are designed to preserve speech,
reathing and swallowing functions of the larynx without altering
urvival. However, the long-term results (presented orally [4] but
nfortunately not yet published) of the ﬁrst [1] prospective study
n this subject revealed a high rate (34%) of “unexplained” deaths
fter chemoradiation, raising the question of the long-term toxic-
ty of these protocols. Analysis of the US National Cancer Data Base
oncerning laryngeal cancer, conducted by Hoffman et al. in 2006
12], demonstrated a reduction of the 5-year survival in the group
f patients treated with chemoradiation compared to the group
reated by surgery.
Patients with advanced (stage III–IV) laryngeal cancer are
herefore faced with a therapeutic dilemma requiring a trade-off
etween preservation of laryngeal function offered by the laryn-
eal preservation protocol or the better survival provided by total
aryngectomy. This classical “trade-off” situation does not only
pply to advanced laryngeal cancer, but also concerns all ﬁelds of
ncology. The most highly publicized examples are prostate can-
er in men: chemoradiation that preserves erectile function versus
rostatectomy, and breast cancer in women: chemoradiation ver-
us mastectomy.
Although several studies in the context of advanced laryn-
eal cancer have emphasized the clinical (early T stage, N0
tatus, absence of cartilage invasion of the pre-epiglottic com-
artment and/or extralaryngeal extension), biological (p53 protein
xpression) or therapeutic factors (major clinical response to
nduction chemotherapy) that can encourage the clinician to
ropose a laryngeal preservation protocol, only very few stud-
es have presented this analysis from the patient’s point of
iew.
The ﬁrst study published on this topic in the New England Jour-
al of Medicine in 1981 by McNeil et al. [10] noted that most
orth American subjects (12 ﬁre-ﬁghters and 25 executives in
ood health) placed in a situation of stage T3 laryngeal can-
er were willing to trade off 15 to 30% of their life expectancy
n order to preserve their larynx. More recently, in a cohort of
09 patients attending the otorhinolaryngology clinic of a French
eaching hospital for various diseases, asked to imagine that they
uffered from advanced laryngeal cancer, we demonstrated that,
lthough 64.5% of subjects of this cohort would consider a reduc-
ion of their survival in order to preserve their larynx, 12.9%
ere unable to take this decision and 24.6% were not prepared
o accept the slightest reduction of their chance of survival even
t the cost of total laryngectomy [11]. Although four variables
n this study (age, level of education, occupation and family his-
ory of cancer) affected the subject’s capacity to take a decision,
one of these factors was able to predict which subjects would
ccept a trade-off of their chances of survival to preserve their
arynx or the percentage survival they were willing to trade off
o preserve their larynx [11]. The present study completes the
ndings of this preliminary study. Analysis of the questionnaires
evealed that 28.6% of subjects would not consider the slightest
rade-off of survival to preserve their larynx and that subjects
illing to trade off survival to preserve their larynx reported a
ery wide range of acceptable percentage trade-off (Fig. 1), rang-
ng from 5 to 100% with a median of 33%. Furthermore, almost
ne half (47.9%) of subjects wanted to receive additional infor-
ation before taking their decision with a statistically signiﬁcantgology, Head and Neck diseases 131 (2014) 93–97
increase in this percentage among subjects with a level of edu-
cation beyond secondary school (P = 0.0006) and among subjects
with a family history of cancer (P = 0.038). The additional informa-
tion most frequently requested (Table 3) concerned complications,
adverse effects and/or risks related to the laryngeal preservation
protocol and the expected cure rates. Finally, after receiving infor-
mation on the risk of tracheostomy and permanent gastrostomy
after laryngeal preservation protocol, the percentage of subjects
who would no longer consider the slightest trade-off in terms of
survival to preserve their larynx increased to 31.2% and 56.1%,
respectively.
These ﬁndings raise a number of comments. The ﬁrst comment
concerns the fact that this study was based on analysis of responses
from patients not presenting the disease studied (advanced laryn-
geal cancer), but simply asked to imagine being faced with this type
of disease. This factor could be considered to constitute a major
bias that would limit all of the proposed conclusions of this study.
However, we  do not believe that this aspect constitutes a major
bias, as a very small percentage (2.3%, Table 3) of subjects in our
study considered that they were unable to answer the questions
raised concerning the treatment options analysed in this study.
Furthermore, the previous study conducted on the same popula-
tion [11] also emphasized the absence of modiﬁcations in terms
of the percentage of subjects that would consider to trade off a
percentage chance of cure in order to preserve their larynx when
comparing patients who were or not yet treated for another head
and neck cancer. The second comment concerns the similarity of
the ﬁgures published in 1981 in the study conducted in the same
ﬁeld by a North American team [10] and our results, suggest-
ing that there is no major difference between the points of view
of American and European patients with respect to the trade-off
between cure and laryngeal preservation that they would consider
if they faced an advanced laryngeal cancer. The third comment
concerns the high percentage of subjects (28.6%) who  would not
consider the slightest reduction of their chance of cure, even at
the cost of total laryngectomy (while only 1.4% of subjects were
willing to lose all chances of cure in order to avoid total laryn-
gectomy) and the fact that this percentage increased to 31.2% and
56.1%, respectively, after subjects had been informed about the
risk of tracheostomy and permanent gastrostomy after a laryngeal
preservation protocol. All of these ﬁgures suggest that total laryn-
gectomy is a treatment option that should be discussed in detail
with patients with advanced laryngeal cancer. Survival ﬁgures can
have a major impact on the patient’s decision to accept or refuse
total laryngectomy in this setting. For instance, in the study by
McNeil et al. [12], none of the subjects included would have con-
sidered radiotherapy as a treatment option if the 3-year survival
after this option was only 30%, while 43% of subjects would have
considered this treatment option as an alternative to total laryn-
gectomy if the 3-year survival was 40%. This impact of survival
rate on the potential decision of an organ preservation protocol in
patients with advanced laryngeal cancer should encourage head
and neck cancer surgeons to be very familiar with quantitative
survival data and to publish the results of clinical trials analysing
survival not as a function of stage (III or IV) alone, but also as
a function of the various known risk factors, particularly clinical
(anatomical site, T and N classiﬁcation, cartilage invasion, invasion
of the pre-epiglottic compartment, extralaryngeal extension) with
a potential impact on survival. Finally, our last comment concerns
the fact that, although many subjects requested additional informa-
tion, very few of them spontaneously considered seeking additional
information from another specialist (5.4%) or their general practi-
tioner (1.5%), requested a period of reﬂection before making their
decision (1.5%) and/or considered that they needed to be reas-
sured (0.7%). In our country, it therefore appears that, although a
detailed information about the disease and the results and risks
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nherent to the various treatment options must be provided to
ur patients, they do not (yet?) express the desire to seek other
pinions.
. Conclusion
This prospective study based on analysis of the point of view
f otorhinolaryngology patients set in a situation to face the diag-
osis of an advanced laryngeal cancer reveals that: (i) laryngeal
reservation is not a primary objective shared by all subjects; (ii)
he percentage chance of cure that subjects would be willing to
rade off to avoid total laryngectomy is extremely variable and (iii)
he information on the major functional risks inherent to laryngeal
reservation protocols has a major impact on the subject’s treat-
ent decision. These elements, combined with a strong desire for
ore detailed information, particularly on cure rates and compli-
ations, must be taken into account by clinicians, especially as a
ecent Court of Cassation decision (decision No. 09-13.591 dated
 June 2010) now considers the failure to provide adequate infor-
ation as a legal fault that generates speciﬁc moral damage that
ay  be subject to compensation, even when no damage arises from
he procedure incriminated and/or when it can be shown that ade-
uate information would not have led the patient to chose another
ption. Under these conditions, the neoadjuvant chemotherapy
reatment option can be particularly useful, as the clinical response
btained can be used to optimally guide the ﬁnal treatment deci-
ion (chemoradiation in good responders and total laryngectomy
n non-responders), while the duration of this ﬁrst-line treatment
ives both the surgeon and the patient time to share good quality
nformation before deciding on the most appropriate ﬁnal treat-
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